A scoping review published in the Journal of Translational Medicine evaluates how artificial intelligence and machine learning drive the in silico design of nanotechnology-based mRNA therapeutics. These mRNA therapeutics are being formulated for cancer immunotherapy, cell therapy, and gene therapy. However, the authors note that these therapeutics remain constrained by manufacturing expenses, bioavailability, and stability issues during development.
According to the review, artificial intelligence and machine learning accelerate development through in silico validation and virtual screening methodologies. These computational tools facilitate formulation optimization, library screening, binding prediction, and rapid analysis across candidate structures.
Despite the advantages of virtual screening, significant challenges impede straightforward clinical translation. The authors highlight substantial data heterogeneity across existing nanoparticle repositories and mRNA databases. This heterogeneity arises primarily from poor data standards, model inconsistency, and persistent literature gaps.
To overcome these limitations, the authors emphasize that generating standardized datasets connecting lipid nanoparticle parameters with mRNA features is essential. In addition, future progress relies on validating computational predictions throughout every stage of the therapeutic process.
The scoping review concludes that integrating nanomedicine, artificial intelligence, machine learning, and mRNA technologies provides a viable framework to formulate precise, personalized, and economical therapeutics.
Subject of Research: Artificial intelligence and machine learning in nanotechnology-based mRNA therapeutic design
Article Title: A scoping review on AI/ML-driven in-silico design of nanotechnology-based mRNA therapeutics: advances, challenges, and prospects
Article References: Jirage, J., Kaknale, S., Bennur, T., Vyas, A., & Manikantan, V. (2026). A scoping review on AI/ML-driven in-silico design of nanotechnology-based mRNA therapeutics: advances, challenges, and prospects. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09229-0
Image Credits: AI Generated
DOI: 10.1186/s12967-026-09229-0
Keywords: mRNA therapeutics, artificial intelligence, machine learning, nanotechnology, in silico design, scoping review, cancer immunotherapy, cell therapy, gene therapy, lipid nanoparticles, virtual screening, formulation optimization, binding prediction, clinical translation, data heterogeneity, data standards, model inconsistency, nanomedicine
News Source: Blake Davidson. (November 17, 2026). Scoping Review Examines Machine Learning for Designing Nanotechnology mRNA Therapeutics. Scienmag.



